# Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

Review · C. Boutros, Ahmad A. Tarhini, Émilie Routier, Olivier Lambotte, François Le Roy Ladurie, Franck Carbonnel, Hassane Izzeddine, Aurélien Marabelle, Stéphane Champiat, Armandine Berdelou, Émilie Lanoy, Matthieu Texier, Cristina Libenciuc, Alexander M.M. Eggermont, Jean‐Charles Soria, Christine Mateus, Caroline Robert

- Archive id: doi:10.1038/nrclinonc.2016.58
- Published: 2016-05-04
- Venue: Nature Reviews Clinical Oncology
- DOI: https://doi.org/10.1038/nrclinonc.2016.58
- PMID: 27141885
- Citations: 1,101
- Source URL: https://doi.org/10.1038/nrclinonc.2016.58
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.